Liberia vs United States of America: Previously treated cases tested for RR-/MDR-TB
Liberia
83.0%
in 2024
United States of America
83.0%
in 2023
Liberia rank
104th
United States of America rank
104th
Previously treated cases tested for RR-/MDR-TB over time
- Liberia
- United States of America
How they compare
Liberia currently reports 83.0% against 83.0% in United States of America, a difference of 0.0%.
The two have swapped places 4 times across 10 shared years of data; in 2013 it was United States of America ahead.
Liberia ranks 104th and United States of America ranks 104th of 180 countries.
United States of America has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Liberia | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 62.8% | 70.7% | 7.8% | United States of America |
| 2020s | 38.8% | 84.8% | 46.0% | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Liberia or United States of America?
- Liberia, at 83.0% against 83.0% in United States of America as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Liberia and United States of America?
- 0.0%, with Liberia ahead.
- How many years of comparable data are there for Liberia and United States of America?
- 10 years are reported by both, from 2013 to 2023.
- How do Liberia and United States of America rank globally for previously treated cases tested for rr-/mdr-tb?
- Liberia ranks 104th and United States of America ranks 104th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.